<DOC>
	<DOCNO>NCT01728883</DOCNO>
	<brief_summary>The purpose study determine effect enhancement myVisionTrack® regard patient compliance test-retest variability . Additionally , ability myVisionTrack® detect change vision function evaluate .</brief_summary>
	<brief_title>Diabetic Retinopathy And Myvisiontrack® ( DRAMA ) Study</brief_title>
	<detailed_description>The result study provide basis patient self-monitoring visual function myVisionTrack® , reporting , storage , maintenance collect data . The myVisionTrack® intend use remotely patient monitor disease . In case significant change , patient prompt visit ophthalmologist . It hypothesize lead early detection disease progression , , turn , lead earlier treatment good prevention vision loss due diabetic retinopathy ( DR ) .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>DR AMD require treatment time study initiation Macular edema involve central subfield base clinical judgment No noticeable central subfield atrophy Patients willing able comply study followup procedure ( include handle myVisionTrack™ device ) Any ocular pathology DR AMD Any concurrent systemic illness affect retina visual function Dementia neurological psychological limitation would prevent patient perform selftesting visual function Past ( within prior 6 month ) current use , likely need , systemic medication know toxic lens , retina , optic nerve Use investigational drug time screening , within 60 day ( exclude vitamin mineral ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Diabetic Retinopathy</keyword>
	<keyword>Diabetic Macular Edema</keyword>
	<keyword>Macular Edema</keyword>
	<keyword>Maculopathy</keyword>
	<keyword>home monitoring</keyword>
	<keyword>shape discrimination hyperacuity</keyword>
	<keyword>Psychophysical Testing</keyword>
</DOC>